Smyraf Tablets 100mg (スマイラフ錠100mg)

देश: जापान

भाषा: अंग्रेज़ी

स्रोत: すりの適正使用協議会 RAD-AR Council, Japan

सक्रिय संघटक:

Peficitinib hydrobromide

थमां उपलब्ध:

Astellas Pharama Inc.

INN (इंटरनेशनल नाम):

Peficitinib hydrobromide

फार्मास्यूटिकल फॉर्म:

pale red tablet, diameter: approx. 9.1 mm, thickness: approx. 4.8 mm

उत्पाद समीक्षा:

Print on wrapping: Smyraf 100mg, スマイラフ100mg, アステラス製薬, company mark

सूचना पत्रक

Drug Information Sheet("Kusuri-no-Shiori")
Internal
Revised: 08/2023
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
SMYRAF TABLETS 100MG
ACTIVE INGREDIENT:
Peficitinib hydrobromide
DOSAGE FORM:
pale red tablet, diameter: approx. 9.1 mm, thickness:
approx. 4.8 mm
IMPRINT OR PRINT ON WRAPPING:
Smyraf 100mg, スマイラフ 100mg, アステラス
製薬, company mark
EFFECTS OF THIS MEDICINE
This medicine suppresses the action of several substances associated
with expression of
inflammation or pain by inhibiting the activity of an enzyme called
Janus Kinase (JAK), thereby
showing improvement on symptoms of rheumatoid arthritis such as pain
or swelling of the
joint.
It is usually used for the treatment of patients with rheumatoid
arthritis (including prevention
of structural joint damage) who have not had shown enough efficacy
with existing therapies.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have: infections, active tuberculosis, liver dysfunction,
neutropenia, lymphopenia,
decreased hemoglobin, intestinal diverticulum (pouch-like cavity
formed in the intestine),
congenital short QT syndrome or a risk of venous thromboembolism.
If you have or have a history of malignant tumor.
If you have a history of interstitial pneumonia or herpes zoster.
If you have a history of tuberculosis or are suspected to have
tuberculous infection.
If you are suspected to have or susceptible to infections.
If you are a hepatitis B virus carrier or have a history of hepatitis
B.
・If you are pregna